Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Week in Review: What to expect at ACC.22 | Medtronic's latest recall | The risks of daily acetaminophen use
Saturday, February 12, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

Long-term risk of heart attack, coronary artery disease or stroke much higher among COVID-19 patients

Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues.

READ MORE >
Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues. #longcovid
Share on Twitter Share on Facebook Share on Linkedin

Long-term risk of heart attack, coronary artery disease or stroke much higher among COVID-19 patients

Share on Twitter Share on Facebook Share on Linkedin
Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues. #longcovid
Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues.
READ MORE >

Links to the ACC.22 late-breaking clinical trials

Learn more about the late-breaking studies presented at ACC.22 in Washington, D.C. 

READ MORE >
The American College of Cardiology (ACC) annual meeting ACC.22 is the premier source for the latest cardiac science. #ACC22 Here are links to all the late breaking studies, trials and late-breaker science at the annual meeting conference. #ACC2022 #ACC
Share on Twitter Share on Facebook Share on Linkedin

Links to the ACC.22 late-breaking clinical trials

Share on Twitter Share on Facebook Share on Linkedin
The American College of Cardiology (ACC) annual meeting ACC.22 is the premier source for the latest cardiac science. #ACC22 Here are links to all the late breaking studies, trials and late-breaker science at the annual meeting conference. #ACC2022 #ACC
Learn more about the late-breaking studies presented at ACC.22 in Washington, D.C. 
READ MORE >

Medtronic recalls a second directional atherectomy device due to risk of tip damage

There have been no incidents at this time, but the device is similar to another Medtronic solution that was recently recalled. 

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

Medtronic recalls a second directional atherectomy device due to risk of tip damage

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
There have been no incidents at this time, but the device is similar to another Medtronic solution that was recently recalled. 
READ MORE >

Too much Tylenol? Daily acetaminophen use may be bad for hypertension patients

Daily acetaminophen use was associated with a “significant increase” in daytime systolic and diastolic blood pressure.

READ MORE >
Apixaban may be a more effective treatment option than rivaroxaban for patients presenting with atrial fibrillation (AFib) and valvular heart disease (VHD), according to a new analysis published in Annals of Internal Medicine.
Share on Twitter Share on Facebook Share on Linkedin

Too much Tylenol? Daily acetaminophen use may be bad for hypertension patients

Share on Twitter Share on Facebook Share on Linkedin
Apixaban may be a more effective treatment option than rivaroxaban for patients presenting with atrial fibrillation (AFib) and valvular heart disease (VHD), according to a new analysis published in Annals of Internal Medicine.
Daily acetaminophen use was associated with a “significant increase” in daytime systolic and diastolic blood pressure.
READ MORE >

HeartFlow calls off plans to merge, go public due to ‘unfavorable market conditions’

The deal, originally announced back in July 2021, valued the new entity at approximately $2.4 billion.

READ MORE >
HeartFlow FFR-CT is a non-invasive imaging method to determine the fractional flow reserve for the entire coronary tree.
Share on Twitter Share on Facebook Share on Linkedin

HeartFlow calls off plans to merge, go public due to ‘unfavorable market conditions’

Share on Twitter Share on Facebook Share on Linkedin
HeartFlow FFR-CT is a non-invasive imaging method to determine the fractional flow reserve for the entire coronary tree.
The deal, originally announced back in July 2021, valued the new entity at approximately $2.4 billion.
READ MORE >

TEE improves 30-day outcomes for patients undergoing cardiac valve or proximal aortic surgery

Intraoperative TEE, researchers wrote, can provide value during any open cardiac valve or proximal aortic surgery.

READ MORE >
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
Share on Twitter Share on Facebook Share on Linkedin

TEE improves 30-day outcomes for patients undergoing cardiac valve or proximal aortic surgery

Share on Twitter Share on Facebook Share on Linkedin
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
Intraoperative TEE, researchers wrote, can provide value during any open cardiac valve or proximal aortic surgery.
READ MORE >

Implantable atrial shunt therapy trial identifies treatable HFpEF patients

The REDUCE LAP-HF II study identified heart failure patients who may benefit from receiving a new transcatheter implant manufactured by Corvia Medical.

READ MORE >
The Corvia Atrial Shunt is designed to address elevated left atrial pressure (LAP) heart failure patients.
Share on Twitter Share on Facebook Share on Linkedin

Implantable atrial shunt therapy trial identifies treatable HFpEF patients

Share on Twitter Share on Facebook Share on Linkedin
The Corvia Atrial Shunt is designed to address elevated left atrial pressure (LAP) heart failure patients.
The REDUCE LAP-HF II study identified heart failure patients who may benefit from receiving a new transcatheter implant manufactured by Corvia Medical.
READ MORE >

Continued anticoagulation after primary PCI boosts survival among STEMI patients

A key takeaway from the group's analysis was that the rate of major bleeding events did not significantly change. 

READ MORE >
elderly patient mask covid
Share on Twitter Share on Facebook Share on Linkedin

Continued anticoagulation after primary PCI boosts survival among STEMI patients

Share on Twitter Share on Facebook Share on Linkedin
elderly patient mask covid
A key takeaway from the group's analysis was that the rate of major bleeding events did not significantly change. 
READ MORE >

First implant of dual-chamber leadless pacemaker completed in Abbott’s Aveir DR i2i pivotal trial

The investigational dual-chamber pacemaker is designed to provide synchronous, beat-by-beat pacing of the right atrium and right ventricle of the heart.

READ MORE >
The Abbott Aveir DR dual-chamber leadless pacemaker recently had its first human implant occur in the Aveir DR i2i study pivotal trial.
Share on Twitter Share on Facebook Share on Linkedin

First implant of dual-chamber leadless pacemaker completed in Abbott’s Aveir DR i2i pivotal trial

Share on Twitter Share on Facebook Share on Linkedin
The Abbott Aveir DR dual-chamber leadless pacemaker recently had its first human implant occur in the Aveir DR i2i study pivotal trial.
The investigational dual-chamber pacemaker is designed to provide synchronous, beat-by-beat pacing of the right atrium and right ventricle of the heart.
READ MORE >

What clinicians need to know about PCI, other revascularization techniques among women

The Society for Cardiovascular Angiography & Interventions has shared a new expert consensus statement that highlights sex-specific considerations associated with revascularization. 

READ MORE >
older female patient and doctor
Share on Twitter Share on Facebook Share on Linkedin

What clinicians need to know about PCI, other revascularization techniques among women

Share on Twitter Share on Facebook Share on Linkedin
older female patient and doctor
The Society for Cardiovascular Angiography & Interventions has shared a new expert consensus statement that highlights sex-specific considerations associated with revascularization. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

The latest on PFA risks | EP catheters recalled | Doctors exempt from work visa freeze | Good news for Heartflow
Top 10 most popular cardiology video interviews this past month
Week in Review: New IVL data | TAVR trend prompts 'call to action' | Compensation climbs | Ablations in ASCs | More recalls
News Alert: Thousands of reprocessed EP catheters recalled
New heart failure device impresses | Cardiac amyloidosis in the spotlight | Experts agree: HFmrEF should not be ignored
Cardiology salaries outpace other specialties | A new TAVR technique | Cardiac amyloidosis in the spotlight | BP drug recalled
A new device warning after 3 deaths | AI predicts stroke risk | FDA clears intravascular imaging tech | IV fluids recalled

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …6
    • Page 7
    • Page 8
    • Page 9
    • Current page 10
    • Page 11
    • Page 12
    • Page 13
    • Page 14 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme